HomeTNYA • NASDAQ
add
Tenaya Therapeutics Inc
Previous close
$1.28
Day range
$1.18 - $1.31
Year range
$0.36 - $4.01
Market cap
195.57M USD
Avg Volume
3.79M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.08M | -21.87% |
Net income | -23.28M | 20.89% |
Net profit margin | — | — |
Earnings per share | -0.14 | 58.82% |
EBITDA | -22.00M | 23.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 71.67M | -27.83% |
Total assets | 122.15M | -25.15% |
Total liabilities | 22.32M | -23.52% |
Total equity | 99.83M | — |
Shares outstanding | 162.98M | — |
Price to book | 2.10 | — |
Return on assets | -45.25% | — |
Return on capital | -49.28% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -23.28M | 20.89% |
Cash from operations | -15.61M | 33.89% |
Cash from investing | 24.99M | 15.60% |
Cash from financing | -476.00K | -183.51% |
Net change in cash | 8.90M | 721.44% |
Free cash flow | -8.89M | 34.73% |
About
Founded
2016
Headquarters
Website
Employees
97